Literature DB >> 23044777

Urological cancer: Aspirin and the risk of prostate cancer mortality.

Carlo La Vecchia, Cristina Bosetti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23044777     DOI： 10.1038/nrclinonc.2012.182

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  10 in total

Review 1.  Aspirin and urologic cancer risk: an update.

Authors:  Cristina Bosetti; Valentina Rosato; Silvano Gallus; Carlo La Vecchia
Journal:  Nat Rev Urol       Date:  2012-01-24       Impact factor: 14.432

Review 2.  The platelet contribution to cancer progression.

Authors:  N M Bambace; C E Holmes
Journal:  J Thromb Haemost       Date:  2011-02       Impact factor: 5.824

Review 3.  COX-2: a molecular target for colorectal cancer prevention.

Authors:  Joanne R Brown; Raymond N DuBois
Journal:  J Clin Oncol       Date:  2005-04-20       Impact factor: 44.544

Review 4.  Contribution of platelets to tumour metastasis.

Authors:  Laurie J Gay; Brunhilde Felding-Habermann
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

Review 5.  Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues.

Authors:  Michael J Thun; S Jane Henley; Carlo Patrono
Journal:  J Natl Cancer Inst       Date:  2002-02-20       Impact factor: 13.506

Review 6.  Aspirin and cancer risk: a quantitative review to 2011.

Authors:  C Bosetti; V Rosato; S Gallus; J Cuzick; C La Vecchia
Journal:  Ann Oncol       Date:  2012-04-19       Impact factor: 32.976

7.  Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy.

Authors:  Kevin S Choe; Janet E Cowan; June M Chan; Peter R Carroll; Anthony V D'Amico; Stanley L Liauw
Journal:  J Clin Oncol       Date:  2012-08-27       Impact factor: 44.544

Review 8.  Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement.

Authors:  Jack Cuzick; Florian Otto; John A Baron; Powel H Brown; John Burn; Peter Greenwald; Janusz Jankowski; Carlo La Vecchia; Frank Meyskens; Hans Jörg Senn; Michael Thun
Journal:  Lancet Oncol       Date:  2009-05       Impact factor: 41.316

9.  Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis.

Authors:  Eric Camerer; Aisha A Qazi; Daniel N Duong; Ivo Cornelissen; Rommel Advincula; Shaun R Coughlin
Journal:  Blood       Date:  2004-03-18       Impact factor: 22.113

10.  Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials.

Authors:  Peter M Rothwell; Michelle Wilson; Jacqueline F Price; Jill F F Belch; Tom W Meade; Ziyah Mehta
Journal:  Lancet       Date:  2012-03-21       Impact factor: 79.321
  10 in total
  2 in total

Review 1.  A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies.

Authors:  Farhad Islami; Daniel M Moreira; Paolo Boffetta; Stephen J Freedland
Journal:  Eur Urol       Date:  2014-09-18       Impact factor: 20.096

2.  Human papillomavirus 16 infection as a potential risk factor for prostate cancer: an adaptive meta-analysis.

Authors:  Jong-Myon Bae
Journal:  Epidemiol Health       Date:  2015-02-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.